Lung cancer screening with low-dose CT and AI in Glasgow
Part of Cancer clinical trials.
This study is testing whether a low-dose CT scan, analyzed with artificial intelligence, can help find lung cancer and other heart or lung conditions early. It may be a good fit if you are a current or former smoker in the Glasgow area and meet the age and smoking history requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in the South Sector of NHS Greater Glasgow and Clyde.
- You are between 55 and 74 years old.
- You are a current smoker or former smoker who quit less than 15 years ago and smoked at least 20 pack-years (e.g., 1 pack per day for 20 years).
- You are able to give consent and do not have an active cancer (except non-melanoma skin cancer, monitored prostate cancer, or treated breast cancer).
- You can lie flat for the scan and weigh less than 200 kg.
- You have not had a chest CT scan in the last 12 months and are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to improve low-dose CT scans for early lung cancer detection. If you are at higher risk due to smoking or family history, or just want a routine check, you may be able to join.
This study tests how well an AI tool can predict lung cancer risk, based on your health information. It looks at how patients feel about this approach to screening, with the goal of making screening more personal and effective.
This study uses artificial intelligence to analyze CT scans and other health data to better identify people at risk for smoking-related diseases like lung cancer. Researchers hope to improve early detection and prevention.
This trial uses artificial intelligence and special imaging tests, like PET/CT and low-dose CT, to find lung cancer early in people at higher risk. It aims to improve how we spot and understand early signs of lung cancer.
This trial tests whether using artificial intelligence (computer pattern-recognition) with lung screening images can help identify people who may have lung cancer earlier. It’s meant for people at higher risk because of their smoking history, who can follow the screening steps.
This study tests a lung cancer screening program using low-dose CT scans and a blood test to find cancer early. It is for people who smoke or used to smoke.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.